| Document |
Document Title |
|
WO/2020/222011A1 |
The invention relates to compounds of formula (IW-1) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: wherein RA, RB, RC and RD are as defined herein.
|
|
WO/2020/222010A1 |
The invention relates to compounds of formula (I) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: (I) wherein R A, R B, R C and R D are as defined herein.
|
|
WO/2020/220651A1 |
Disclosed are a method for synthesizing a chiral 2-hydroxy-1,4-dicarbonyl compound by using a tetrapeptide TP or an enantiomer ent-TP thereof as a chiral catalyst to catalyze an asymmetric Aldol reaction between fatty aldehyde and glyoxy...
|
|
WO/2020/218365A1 |
[Problem] To provide a curable composition which has excellent curability, preferably can contain water that is environment-friendly, can be cured into a cured film having excellent adhesiveness to a base material, particularly to a plas...
|
|
WO/2020/215357A1 |
The present invention provides a method for preparing a chiral β-hydroxycarboxylate compound: first, under nitrogen protection, dissolving [Ir(COD)Cl]2, a ligand, and an alkaline additive in a solvent, and stirring same at room temperat...
|
|
WO/2020/214693A1 |
Provided herein are novel monomethyl fumarate prodrugs.
|
|
WO/2020/212543A1 |
The present invention relates to novel ophthalmic devices comprising polymerized compounds comprising a photoactive unit, said polymerized compounds, and special monomer compounds being particularly suitable for compositions and ophthalm...
|
|
WO/2020/210920A1 |
Methods, compositions and uses for inhibiting the growth in blood cancer cells in a patient with one or more of a caffeic acid phenpropyl ester (GL8) analogue selected from the group consisting of As26, J229, J91, LL27, LL23, HM7, As25, ...
|
|
WO/2020/212872A1 |
There is provided a metal or metal-ion battery comprising an aluminum current collector and a low-corrosiveness non-aqueous electrolyte comprising, as a solvent, a carbonate compound of formula (I): (I). This battery has an upper voltage...
|
|
WO/2020/213470A1 |
A dicarboxylic acid or a derivative thereof according to the present invention is represented by formula (I). (In the formula, Z1a and Z1b are arene rings, R1a and R1b are substituents, k1 and k2 are integers of at least 0, m1 and m2 are...
|
|
WO/2020/209952A1 |
LAO dimers comprising a vinylidene group or a hydrogenated reaction product thereof may be used to form various wax compositions that may increase the quality of otherwise low-quality waxes. Wax compositions having a melting point of 40 ...
|
|
WO/2020/207952A1 |
The invention discloses the use of activated carbon with a mesh size smaller than 80 for the decolorization of acetoacetylated glycerol.
|
|
WO/2020/209035A1 |
A compound represented by formula (1). R1 is, for example, an alkyl having 1-15 carbon atoms; ring A1 and ring A2 are 1,4-phenylene, etc.; a is 2, etc.; b and c are 0, 1, or 2; Z1 is a single bond, etc.; P1 and P2 are polymerizable group...
|
|
WO/2020/198883A1 |
Transdermal medicaments containing cannabidiol (CBD) for use in the amelioration of conditions, including anxiety, depression, pain, inflammation, epilepsy, parkinson's disease, oxidative injury and nausea; and a method for preparing same.
|
|
WO/2020/203491A1 |
The present invention addresses the problem of providing: a compound which is capable of reducing the tilt angle of a liquid crystal molecule; a polymerizable composition which uses this compound; a cured product; an optical film; a pola...
|
|
WO/2020/198874A1 |
There are provided various cannabidiolic acid monoglycerides and derivatives thereof. These compounds can be useful as an inflammation resolution agent, anti-inflammatory agent, cancer chemopreventive agent, mitochondrial modulator agent...
|
|
WO/2020/203519A1 |
The present invention addresses the problem of providing: a compound that has liquid crystal properties over a wide temperature range, demonstrates excellent precipitation suppression, and has excellent solubility; and a polymerizable co...
|
|
WO/2020/199081A1 |
The present invention provides a method for preparing a 2-arylmalonic acid derivative, an intermediate, and an application thereof. In the method, a cyclohexadiene compound is taken as a raw material, and isomerization reaction, halogena...
|
|
WO/2020/201534A1 |
The invention disloses a method for preparation of an acetoacetylated polyol by reaction of a polyol with deketene in the presence of a base and in the absence of a solvent.
|
|
WO/2020/203580A1 |
The present invention provides a method for producing a hetero type monodisperse polyethylene glycol having a step (A) for subjecting a compound of formula (2) and a compound of formula (3) to a nucleophilic substitution reaction so as t...
|
|
WO/2020/205470A1 |
The present disclosure provides compounds and methods for inhibiting or degrading the N-terminal domain of the androgen receptor, as well as methods for treating cancers such as prostate cancer.
|
|
WO/2020/201974A1 |
The present invention relates to a novel process for preparation of compounds of formula (I) used in the synthesis of Pinoxaden. The intermediate is a substituted phenyl malonic esters of formula (I), where R is C1-C4 alkyl, straight or ...
|
|
WO/2020/198940A1 |
Provided is a crystal form A of 2-(2,5-dioxopyrrolidin-1yl)ethylmethylfumarate. The crystal form has a good light irradiation stability, high-temperature stability and high-humidity stability.
|
|
WO/2020/203444A1 |
A compound which has, between end groups arranged at both ends and each having a reactive group, a first structure wherein an aromatic ring group, an ether oxygen atom, a methylene group, an aromatic ring group, a methylene group, an eth...
|
|
WO/2020/193387A1 |
Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as fungicides.
|
|
WO/2020/192348A1 |
Disclosed are phenyl allylidene cyclohexenone derivatives with the structure shown in general formula I. In combination with structural characteristics and structure-function relationship of piplartine, amino bonds are replaced with doub...
|
|
WO/2020/191477A1 |
The application relates to a lipid conjugate of formula M-X1-L wherein M is a molecule of interest such as a drug moiety; X1 is a linker group such as ester, ether or carbamate; and L is a lipid scaffold represented by formula (lId): -L1...
|
|
WO/2020/193681A1 |
The present invention relates to derivatives of 10-methylene lipids, their preparation and their use.
|
|
WO/2020/196150A1 |
This molded catalyst body is used in order to produce an unsaturated aldehyde and/or an unsaturated carboxylic acid by means of an oxidation reaction, and simultaneously satisfies requirements (A) and (B). (A) Before being filled in a re...
|
|
WO/2020/189621A1 |
The present invention provides a method for producing a peptide containing an N-alkyl amino acid, the method comprising the following steps (1) to (3). Step (1): Mix an N-terminus protected amino acid or an N-terminus protected peptide w...
|
|
WO/2020/182138A1 |
Provided is a method for improving a reaction yield. By using the method of the present invention, after a reaction product leaves a catalyst bed, an inert substance with a low temperature is sprayed, and through heat absorption and vapo...
|
|
WO/2020/184616A1 |
The present invention provides a catalyst in which an alkali metal element and at least one first metal element selected from among boron, magnesium, zirconium and hafnium are supported by a silanol group-containing carrier, wherein the ...
|
|
WO/2020/184142A1 |
[Problem] To provide a compound which has high stability with respect to heat, high voltage holding ratio if used in a liquid crystal display element, and the like. [Solution] A compound which is represented by formula (1). In the formul...
|
|
WO/2020/184306A1 |
Provided is a production method for an organic solvent that contains less metal impurities which cause minute defects on a wafer in a lithography step when manufacturing a semiconductor device, or a method for reducing metals in an organ...
|
|
WO/2020/184642A1 |
Provided is a composition for forming a resist underlayer film that is insoluble in resist solvents, has favorable optical constants, and has a high etching rate. The composition has excellent ability to fill and flatten stepped substrat...
|
|
WO/2020/180249A1 |
The present invention relates to a process for preparing a fatty acid, a fatty acid obtainable by said process, a composition comprising said fatty acid, an eye drop comprising said fatty acid and a method for treating dry eye disease or...
|
|
WO/2020/177044A1 |
Disclosed in the present invention are an ester of validoxylamine A, preparation therefor and antimicrobial use thereof. The structure of the ester of validoxylamine A is as shown below, wherein in R1-R8, R1 is RCO-, R2 is RCO- or H, and...
|
|
WO/2020/173818A1 |
The present invention relates to a method for purifying benzene polycarboxylic acid esters and for producing cyclohexane polycarboxylic acid esters by hydrogenating the purified benzene polycarboxylic acid esters. The invention also rela...
|
|
WO/2020/175185A1 |
The present invention addresses the problem of providing a compound which has an excellent rate of HTP change due to exposure to light. Also, the present invention addresses another problem of providing a composition, a cured product, an...
|
|
WO/2020/175241A1 |
A compound represented by formula (1). In formula (1), R represents a linear, branched, or cyclic alkyl group having 1-4 carbon atoms.
|
|
WO/2020/175420A1 |
In a method for producing an α,β-unsaturated dicarboxylic acid ester exemplified by an α-hydromuconic acid ester from a carboxylic acid ester exemplified by a 3-hydroxyadipic acid ester or a 3-hydroxyadipic acid-3,6-lactone ester, the...
|
|
WO/2020/171039A1 |
This invention addresses the problem of providing a novel fluorene compound, which has a 2,3-benzofluorene skeleton, is highly versatile as a "dicarboxylic acid component" of a resin starting material, has a high refractive index, and is...
|
|
WO/2020/166093A1 |
The purpose of the present invention is to provide a method for selectively producing a hydroxycarboxylic acid ester by reducing a dicarboxylic acid monoester by means of a heterogeneous reaction. A method for producing a hydroxycarbox...
|
|
WO/2020/165613A1 |
The present invention relates to a method for obtaining in pure form or in a mixture the oleacein and oleomissional substances from olive fruits and leaves and certain derivatives thereof, the bioactive diol forms, by selective extractio...
|
|
WO/2020/162371A1 |
The present invention provides: a fluorine-containing ether compound that has excellent chemical resistance; a fluorine-containing ether composition; a coating liquid; an article having a surface layer that has excellent chemical resista...
|
|
WO/2020/129944A9 |
The objective of the present invention is to provide an ester-based lubricating base oil for a fluid dynamic bearing, the lubricating base oil having a high viscosity index and having excellent evaporation resistance, hydrolysis stabilit...
|
|
WO/2020/162537A1 |
The purpose of the present invention is to provide an ester compound that can be used in a resin composition that has excellent heat resistance and dielectric properties after curing. Additionally, the purpose of the present invention is...
|
|
WO/2020/162156A1 |
The present invention provides a compound which enables a light emitting element to have excellent luminance life. A compound which is represented by formula (1). (In the formula, n represents an integer of from 2 to 20 (inclusive); ...
|
|
WO/2020/158931A1 |
The purpose of the present invention is to provide: a novel compound which is useful as a film forming material for lithography or as a material for forming an optical component; a resin which contains a constituent unit that is derived ...
|
|
WO/2020/158047A1 |
In the present invention, when 2,2-dimethyl-3-((Z)-1-propenyl)cyclopropane carboxylic acid methyl and [4-(methoxymethyl)-2,3,5,6-tetrafluorophenyl]methanol are reacted in an organic solvent in the presence of lithium methoxide to produce...
|
